key: cord-0835377-ieimnhbg authors: Greene, Alison; Sapp, John; Hirsch, Greg; Sandila, Navjot; Quraishi, Ata; El-Khateeb, Osama; Kirkland, Susan; Stewart, Robert; Anderson, Kim; Chedrawy, Edgar; Campbell, Samuel; Herman, Christine; Goldstein, Judah; Carter, Alexandra; Andreou, Pantelis; Collins, Adair; Travers, Andrew; Parkash, Ratika title: Cardiovascular Outcomes in Nova Scotia during the Early Phase of the COVID-19 Pandemic date: 2021-12-24 journal: CJC Open DOI: 10.1016/j.cjco.2021.12.008 sha: 658ed0eebb3c6f93d1534afcada193f68804d408 doc_id: 835377 cord_uid: ieimnhbg BACKGROUND: This study sought to determine the impact of the pandemic response to healthcare delivery on outcomes in patients with cardiovascular disease. METHODS: This is a population-based cohort study performed in the province of Nova Scotia (population 979,499), between Pre-COVID (March 1, 2017 – March 16, 2020) and in-COVID (March 17, 2020 – December 31, 2020) periods. Adult patients (≥18 years) with new onset or existing cardiovascular disease were included for comparison between periods. The main outcome measures included: cardiovascular emergency department visits or hospitalizations, mortality, and out-of-hospital cardiac arrest. RESULTS: In the first month of the in-COVID period, emergency department visits (n=51,750) for cardiac symptoms decreased by 20.8% (95% CI 14.0% - 27.0%, p<0.001). Cardiovascular hospitalizations (n=20 609) declined by 48.1% (95% CI 40.4% to 54.9%, p<0.001). In-hospital mortality rate increased in patients with cardiovascular admissions in secondary care institutions by 55.1% (95%CI 10.1%-118%, p=0.013). A decline of 20.4% - 44.0% occurred in cardiovascular surgical/interventional procedures. Out-of-hospital cardiac arrests (n=5528) increased from a monthly mean of 115±15 to 136±14, beginning in May, 2020. Mortality for ambulatory patients awaiting cardiac intervention (n=14,083) increased from 0.16% (n=12501) to 2.49% (n=361) in the in-COVID period (p<0.0001). CONCLUSION: This study demonstrates increased cardiovascular morbidity and mortality during restrictions maintained during COVID-19, in an area with low burden of COVID-19 disease. As the healthcare system recovers or enters subsequent waves of COVID-19, these findings should inform communication to the public regarding cardiovascular symptoms and policy for delivery of cardiovascular care. In March 2020, the novel coronavirus (SARS CoV-2) and the ensuing COVID-19 pandemic changed the delivery of healthcare services around the world. Large numbers of critically ill patients pushed multiple healthcare systems to the brink of collapse. 1 In preparation for surges of COVID-19 cases with attendant need for acute and critical care resources, hospitals markedly reduced the delivery of non-COVID services in anticipation of the need to liberate resources and curtail spread of disease among patients and healthcare workers. 2 A lack of accurate predictive models resulted in a cautious approach with severe reduction in non-COVID-19 care, particularly in scheduled procedures that could result in patient admission. 1 Heart disease remains a leading cause of death globally 3 and requires time-sensitive therapy to prevent significant morbidity and mortality. 4 Due to the COVID-19 pandemic, severe restrictions on some cardiovascular procedures were implemented, limiting care. 5 In jurisdictions with high early burdens of COVID-19 in the community, dramatically increased rates of out of hospital cardiac arrest were observed. 6, 7 It was uncertain whether this was due to unexpected deaths at home from COVID-19, or from the combined effects of public avoidance of healthcare institutions and restricted access to care. 8, 9 On March 16, 2020, a series of public health-mandated measures to reduce the spread of COVID-19 were implemented in the province of Nova Scotia. This resulted in restricted access to ambulatory, elective, and non-urgent medical and surgical procedures, including valvular and revascularization procedures. 10 This included no inpatient transfers for cardiac catheterization for patients that weren't emergent, no elective ambulatory procedures including catheter ablation, device implantation, cardiac catheterization, or cardiovascular surgery. These measures J o u r n a l P r e -p r o o f remained in effect for the first month of the in-COVID period, and were gradually loosened based on COVID infection rates in the province. We performed this study to determine the effect of healthcare restrictions and the public response on outcomes in cardiovascular disease. Healthcare in the province of Nova Scotia, Canada (population of 979,449) 11 is delivered via a single emergency/ambulance system, and a single payer system across a network of 36 hospitals in a regionalized system of secondary care and a single tertiary/quaternary referral center. There are four health authority zones in the province based on region -Western, Eastern, Northern, and Central. Central Zone encompasses the capital city of Halifax, Halifax County and West Hants. The Queen Elizabeth II Health Sciences Centre (QEII HSC) in Halifax, Nova Scotia, is the only institution in the province that provides tertiary and quaternary cardiovascular care and serves the network of 36 peripheral hospitals. The healthcare system is public and universal with no parallel private system. This makes complete data capture possible. During the time period of this study, early aggressive public health measures resulted in minimal community spread of COVID-19 and no major surge in hospitalizations for COVID-19. The COVID-19 hospitalization rate in the province ranged from 0-8 patients/day during the study period. 12 Adult patients (18+ years) were included in the study with a cardiovascular diagnosis, as listed in Table 1 . The data sources for each of the cardiovascular diagnoses are listed in Table 1 . Comprehensive emergency department (ED) visit data was available within the central zone of the province, which utilized a shared electronic medical record, and provides data directly into the National Ambulatory Care Reporting System (NACRS). Hospitalized patients who weren't transferred for acute cardiovascular care (i.e. admitted to secondary care institutions) were identified and analysed separately. Demographic data of ambulatory patients awaiting cardiac interventional procedures was collected through the electronic medical record, all of which are performed at the tertiary care center, resulting in complete data capture for the province. This data was collected by trained research personnel and held in a Redcap database for procedural outcomes, and in an Excel spreadsheet for surgical outcomes. The outcomes included rates of ED visits and hospitalization for acute cardiovascular disease, rates of out-of-hospital cardiac arrest (OOHCA), and rates of ST-elevation myocardial infarction (STEMI), in-hospital and 30-day mortality, and mortality while awaiting a procedure. For patients admitted to the ED, the Canadian Triage Acuity Score was assessed. 13 For patients with STEMI, other outcomes measured included time to balloon, ejection fraction, and enddiastolic pressure at the time of cardiac catheterization. Baseline characteristics were summarized as means (SD) or counts (frequency percentages) where appropriate. Differences in means between the Pre-COVID and in-COVID groups were compared using the independent samples t-test for continuous variables; differences in proportions were compared using the chi-squared or Fisher's Exact test (when expected cell counts were less than 5) for categorical variables. Interrupted Time Series (ITS) analysis using segmented Poisson regression models were performed to compare trends in Pre-COVID and in-COVID cardiovascular event rates, including hospitalizations, for all cardiovascular diagnoses, in-hospital and 30-day mortality. Segmented Poisson models were used to assess the immediate (defined as first month of the in-COVID period, level change) and over time (trend change) effect of the implemented reductions and restrictions on March 17, 2020. Models were assessed for overdispersion using a regressionbased test for overdispersion and seasonality using plots of residuals, autocorrelation functions and partial autocorrelation functions. They were adjusted using a quasi-poisson model and Fourier terms, respectively, as needed. Results from the ITS analysis are presented in the form of level and trend differences. 14 Change point analysis was performed for PPCI and cardiac arrest admissions using four approaches -Bayesian 15 , segmented method (changes in regression) 16 , regression tree 17 A two-sided P-value of <0.05 was used as the threshold for statistical significance. Statistical analysis was carried out using SAS Version 9.4. The study was approved by the Nova Scotia Health Authority Ethics Board on May 6, 2020 (File #1025720). The numbers of patients included in the study are outlined in Figure 1 , with a total of 91,970 patients represented in the study with cardiovascular disease. During the study period, there were 51,750 visits to the ED for acute cardiac symptoms and 14,083 patients awaiting ambulatory cardiac interventional procedures. There were 20,609 cardiovascular hospitalizations, 5528 OOHCAs from March 1, 2017, to December 31, 2020.Baseline demographic data for the study population is presented in Table 2 . In March 2020, the number of ED visits for cardiac diagnoses declined by 20.8% (95% CI 14.0%-27.0%, p<0.001) in the immediate COVID period. Thereafter, ED visits increased by J o u r n a l P r e -p r o o f 2.6% every month, returning to pre-pandemic levels eight months after the onset of restrictions. No difference in rate of admission to hospital or mortality rate in the ED were found between the two periods. Change in ED visits for specific diagnoses are shown in Table 3 and Figure 2 . The Canadian Triage Acuity Score demonstrated no change pre and in-COVID. No change in OOHCAs were observed immediately in the in-COVID period, however, OOHCAs (n=5528) increased from a mean of 11614 to 13614 beginning in May 2020 ( Figure 3 ). Monthly OOHCA displayed seasonal variation from 2017-2019, falling from a mean of 126.9 arrests during winter months to 106.8 arrests during summer months. In 2020, OOHCAs did not diminish during summer months, but rather increased, with a mean of 137.7 events from June to August. Using the regression tree method for identification of a change point, May 2020 was identified as a point at which OOHCA increased, above the 95% confidence interval. Other change points that were identified were in keeping with the seasonal variation described abovei.e. a decrease each summer and increase in the winter. In May 2020, OOHCA increased, disparate to the preceding pattern. (Figure 3 ). The increased OOHCAs demonstrated no differences in proportional increase between men and women. There were 20 609 cardiovascular hospitalizations during the study period. In the first month of in-COVID, acute cardiovascular hospitalizations decreased by 48.1% (95% CI 40.4% -54.9%, p<0.001). The weekly mortality rate for those that were admitted demonstrated an increase by 55.1% (95%CI 10.1%-118%, p=0.013) in the in-COVID group, with a reduction in J o u r n a l P r e -p r o o f mortality by 6.1% per week (95% CI 1.3% -10.6%, p=0.012) thereafter. The rate returned to pre-COVID levels within 9 weeks. Most admissions for cardiovascular reasons declined significantly except for STEMI ( Figure 4 ). In-hospital mortality rates were associated with an increase for patients presenting with NSTEMI (10.6%/week (95%CI 0.9% -19.3%, p=0.03), and HF (7.5%/week (95%CI 2.2% -12.4%, p=0.006) ( Figure 5 ). There were 13,603 patients transferred from the regional care centers to the tertiary/quaternary care institution. Reductions in patient transfer, as dictated by COVID-19 restrictions, to the tertiary care center occurred in the immediate in-COVID period. A trend to an increase in in-hospital mortality by 38.6% (95% CI 5% -102%, p=0.090) in the secondary care hospitals in the month following onset of the in-COVID period occurred. Patients admitted to a secondary care hospital with HF had a 74.3% (95%CI 17.0% -160%, p=0.006) increase in weekly in-hospital mortality rate in the first month. Patients admitted with STEMI and NSTEMI had no significant change in the weekly in-hospital mortality rate. (Figure 6 ) A 44% reduction in cardiac catheterization was observed in the in-COVID period ( Figure 7 ). The mortality rate for ambulatory cardiac catheterization and PCI procedures increased from 0.15% in Pre-COVID patients to 2.63% in patients from the in-COVID period (p<0.0001). Other procedures did not exhibit a statistically significant increase in waitlist mortality in in-COVID. Patients awaiting TAVR exhibited a trend towards increasing mortality from no deaths to 9.52% of patients on the waitlist (p=0.1524). Ambulatory patients undergoing cardiac surgical J o u r n a l P r e -p r o o f procedures decreased by 20.3% in the first month of the in-COVID period. In patients scheduled for CABG, this rate exhibited a trend towards increased mortality from 0.38% in the Pre-COVID group to 0.94% in the COVID group (p=0.4272). Other cardiac surgical procedures did not exhibit a difference in mortality for ambulatory patients. (Figure 8 ) STEMI presentation increased from 598/month to 6510/month in the in-COVID period (p=0.08). Using the trend partition-segmented method, there were six splits, one of which was May 2020. This was the only identified time after the onset of the pandemic where an increasing number of patients presented for primary or rescue PCI for STEMI ( Figure 9 ). In the years prior, This study quantifies the impact that reductions in healthcare delivery due to the first wave of COVID-19 had on outcomes in patients with new onset or existing cardiovascular disease in an area with a low burden of COVID-19 disease. A reduction in cardiac service delivery and reductions in cardiovascular ED visits was followed by increased mortality rates for patients awaiting intervention for coronary disease. While fewer hospitalizations occurred, inhospital mortality rates increased, particularly in patients with HF. An increased rate of OOHCA and STEMI was observed in the months following the onset of these restrictions. Multiple factors may have led to these observed changes. Firstly, during the course of this study, there was a low burden of COVID-19 in Nova Scotia 12 making it more likely that the observed changes were due to the effects of public avoidance of hospital care and to restricted healthcare delivery, rather than to the impact of COVID-19 disease itself. Emergency visits for cardiovascular reasons rapidly declined in the initial COVID period, as public health measures promoted 'stay-at-home' orders with the goal of 'flattening the curve'. We observed a slow return of visits for cardiovascular causes to the pre-pandemic levels due to ongoing concern, despite having few cases of COVID-19 (n=106/100,000) in the province. This may have resulted in patients who would normally have sought medical attention instead choosing to remain at home due to fear of presenting to hospital and the possibility of contracting a Covid-19 infection. 8, 9 Such action could have led to missed opportunities for effective intervention earlier in the course of a cardiac or neurovascular event, and to higher OOHCA rates. Lack of access to primary care physicians may have led to patients having more advanced symptoms. The increased mortality rate in patients admitted with HF in the in-COVID period may reflect a higher acuity of patients admitted to hospital, although lack of access to heart function clinics J o u r n a l P r e -p r o o f and primary care, lack of transfer for advanced therapies to the tertiary care center cannot be excluded as a contributor. Prior studies have found similar trends in HF, acute coronary syndromes and OOHCA. 18, 6, 19, 20 One of the differences in our study, compared to these studies, was a delayed increase in OOHCA and STEMI. It is possible that the increase in OOHCA and STEMI in these other studies could have been directly due to COVID-19. [21] [22] [23] Our observations may provide some insight into the effects of significant lack of access to cardiovascular care other regions may face once the pandemic subsides globally, with the caveat that the uncertainty of the pandemic and public fears may be significantly reduced. There are some limitations to consider when interpreting the findings of our study. Due to low levels of the COVID-19 virus, our findings likely underestimate the morbidity/mortality from cardiovascular disease that result directly from COVID-19 infections; however, the low burden of COVID-19 disease allows us to infer that our observations are more likely to be due to the effects of healthcare restrictions and to public behaviour in response to the pandemic. The policies enacted in our province may differ from other jurisdictions and may not be generalizable. Interruption of services may have varied across the country, particularly early on in the pandemic. The Canadian Cardiovascular Society COVID-19 Rapid Response Team attempted to provide guidance on how cardiac procedures should be limited in relation to the threat of the pandemic to provide some homogeneity across the country, however, this document was not released until December 1, 2020. 24 This study used a quasi-experimental design with possible bias due to the differing timepoints used in the comparison cohorts; the analysis does J o u r n a l P r e -p r o o f not prove causation. Both change point analysis and interrupted time series are sensitive to changes that occur over short periods of time, and provide changes that would be detected due to seasonal variation, the trends we observed were important due to differences during in-COVID as compared to prior observations regarding seasonal variation for the years 2017-2019, providing support for the observations being due to changes enacted during the COVID period. Nevertheless, these observations are exploratory and are subject to interpretation bias. The use of administrative data precluded obtaining patient-level characteristics to compare pre and post COVID in the entire cohort. The follow up in our study is limited, hence further studies investigating longer term outcomes are required. This study demonstrates increased cardiovascular morbidity and mortality as a result of indirect effects of COVID-19-related health care measures in a population with low burden of COVID-19 disease. As the healthcare system recovers or enters subsequent waves of COVID-19, these findings should inform policy surrounding healthcare delivery and public health communications regarding the importance of red flag symptoms in cardiovascular disease. Models promoting increased efficiency to cardiovascular care may be critical during the recovery from the pandemic to account for the higher burden of cardiovascular disease that is likely to surface. The data that support the findings of this study are available from the corresponding author upon reasonable request. Modelling the backlog of COVID-19 cases for a surgical group Cardiothoracic Surgical Advocacy in a Time of COVID-19 The Top Ten Causes of Death Guidelines for the Early Management of Patients with Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke a Guideline for Healthcare Professionals from the Cardiovascular Care Delivery During the Second Wave of COVID-19 in Canada Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic Deaths from Cardiac Arrests have Surged in New York City. The Economist The Fear of COVID-19 Scale: Development and Initial Validation Medicine and Society The Untold Toll -The Pandemic ' s Effects on Patients without Covid-19 Restated Order #2 of the Chief Medical Officer of Health Under Section 32 of the Health Protection Act Population Estimates, Quarterly. Stats Canada Public Health Agency of Canada. COVID-19 Daily Epidemiology Update. Coronavirus disease (COVID-19): For health professionals Revisions to the Canadian Emergency Department Triage and Acuity Scale (CTAS) Guidelines Regression-based tests for overdispersion in the Poisson Model A Bayesian Analysis for Change Point Problems Estimating regression models with unknown break-points Classification and Regression Trees. 1st Editio. Routledge Reduced Rate of Hospital Presentations for Heart Failure During the COVID-19 Pandemic in Toronto Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic The impact of the COVID-19 pandemic on acute coronary syndrome admissions to a tertiary care hospital in Portugal Characteristics Associated with Out-of-Hospital Cardiac Arrests and Resuscitations during the Novel Coronavirus Disease a population-based, observational study. The Lancet Public Health Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy GUIDANCE FROM THE CCS COVID-19 RAPID RESPONSE TEAM Guidance on Community-based Care of the Cardiovascular Patient During the COVID-19 Pandemic Improving cardiovascular outcomes in Nova Scotia (ICONS): a successful public-private partnership in primary healthcare Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Percutaneous Coronary Intervention Onset of COVID Restrictions Funding for this project was received from the Nova Scotia Health COVID-19 Research Coalition. The authors have no disclosures.